-+ 0.00%
-+ 0.00%
-+ 0.00%

ALX Oncology Holdings Q1 Adj. EPS $(0.15) Beats $(0.22) Estimate

Benzinga·05/08/2026 12:02:56
Listen to the news
ALX Oncology Holdings (NASDAQ:ALXO) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.22) by 31.82 percent. This is a 68.75 percent increase over losses of $(0.48) per share from the same period last year.